The current CARA market cap is 49.6M. The company's latest EPS is USD -1.5638 and P/E is -0.58.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10.81M | 3.26M | 6.17M | 6.93M | 4.87M |
Operating Income | -23.85M | -31.31M | -27.65M | -32.34M | -28.9M |
Net Income | -23.18M | -30.34M | -26.67M | -31.48M | -28.03M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 13.47M | 19.89M | 135.08M | 23.03M | 41.87M |
Operating Income | -77.38M | -111.68M | 5.39M | -89.08M | -87.54M |
Net Income | -74.01M | -106.37M | 8.41M | -88.44M | -85.47M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 213.51M | 182.24M | 153.28M | 134.39M | 115.34M |
Total Liabilities | 28.69M | 23.46M | 16.68M | 25.46M | 29.7M |
Total Equity | 184.82M | 158.78M | 136.6M | 108.93M | 85.64M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 190.82M | 232.96M | 271.16M | 247.06M | 182.24M |
Total Liabilities | 57.19M | 46.25M | 22.16M | 19.53M | 23.46M |
Total Equity | 133.63M | 186.71M | 249M | 227.52M | 158.78M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -55.22M | -78.73M | -34.62M | -55.06M | -74.71M |
Investing | 84.28M | 128.71M | 17.71M | 50.51M | 73.67M |
Financing | 289k | 311k | 560k | 560k | 1.68M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -22.3M | -109.23M | -5.49M | -60.09M | -78.73M |
Investing | -82.82M | -30.52M | -20.28M | -4.75M | 128.71M |
Financing | 110.81M | 142.6M | 39.14M | 46.61M | 311k |
Market Cap | 49.6M |
Price to Earnings Ratio | -0.58 |
Price to Sales Ratio | 1.19 |
Price to Cash Ratio | 0.78 |
Price to Book Ratio | 0.31 |
Dividend Yield | - |
Shares Outstanding | 54.66M |
Average Volume (1 week) | 651.12k |
Average Volume (1 Month) | 1.08M |
52 Week Change | -83.50% |
52 Week High | 5.535 |
52 Week Low | 0.50 |
Spread (Intraday) | 0.04 (4.35%) |
Company Name | Cara Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.caratherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.